George Brady

George is a partner in the firm's Corporate M&A Group. In over 25 years of practice, he has advised on many of the most significant and complex Irish corporate transactions across a range of industry sectors.

George is listed as a leading corporate lawyer across a range of publications including IFLR1000, Chambers Europe and The Legal 500.

Mergers & Acquisitions

George's representative M&A transactions include many of the most significant takeovers (hostile and friendly) and mergers of Irish listed companies including; Independent News & Media / Mediahuis; IFG / Epiris; Allergan / Actavis ($66 billion); Willis / Towers Watson (merger of equals); Royalty Pharma / Elan (hostile takeover); Questcor / Mallinckrodt ($5.6 billion); Medtronic / Covidien ($42.9 billion); Actavis / Warner Chilcott ($8.5 billion); Auxilium / Endo International ($2.6 billion); and Worldview / Petroceltic (hostile takeover).

Private Equity

George also acts for a range of Private Equity institutions across a range of industry sectors, in particular Energy, Infrastructure and Telecoms. Recent mandates include advising Asterion Industrial Partners; AMP Capital; Aurelius; Bain Capital; Carlyle Cardinal Ireland; EQT; GLIL Infrastructure; Insight Venture Partners; the Irish Strategic Investment Fund; Macquarie Asset Management; and Partners Group.

George previously worked in the London office of a leading international law firm and has been a partner in Matheson since 2003.